Pune, India -- (SBWire) -- 12/13/2018 --Drug Discovery Services Market is the process of designing a new drug. The most common methods employed for drug discovery are molecular manipulation, random screening, drug metabolites, molecular designing, and serendipity. Drug discovery services are specifically designed to minimize the costs and timelines of drug discovery.
Drug Discovery Services Market Is Expected to Grow At A CAGR Of 10.8% During The Forecast Period Of 2017–2023.
Owing to the rising demand for cancer treatment, technological advancements, increasing healthcare expenditure, growing awareness about chronic diseases, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the drug discovery services market has evolved significantly.
World Drug Discovery Services Market Top 10+ Players Detailed Overview:
Abbott Laboratories Inc., Advinus Therapeutics, Agilent Technologies Ubiquigent, Albany Molecular Research Inc. (AMRI), AstraZeneca PLC, Aurigene, Bayer AG, Charles River Laboratories International, ChemBridge Corporation, Covance, Eli Lilly and Company, Evotec, Domainex, F. Hoffmann-La Roche Ltd, GE Healthcare, GenScript, GlaxoSmithKline LLC, GVK Biosciences, Jubilant Biosys, Lonza, Merck, Pharmaceutical Product Development, LLC (PPD), Piramal Enterprises, Promega Corporation, Selcia Limited, Shimadzu Corp., SRI International, Syngene International Ltd., Thermo Fisher Scientific, Viva Biotech, WuXi AppTec and others.
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/5870
Global Drug Discovery Services Market Regional Analysis:
The Americas dominates the drug discovery services market owing to the increasing prevalence of chronic diseases and healthcare expenditure. According to the data suggested by the Center for Disease Control and Prevention (CDC), around 92.1 million adults have at least one type of cardiovascular disease. It is also reported that around 15.1% of adults in the United States i.e. 36.5 million adults smoked cigarettes in 2015, which accounted for more than 480,000 deaths each year. Nearly 86% of the healthcare cost in the United States i.e. USD 2.7 trillion is spent for people with chronic and mental health conditions.
Europe holds the second position in the drug discovery services market. The financial support by the government towards research and development and patent expiration of various blockbuster drugs are expected to drive the European drug discovery services market. Various biologic drugs such as Genentech's Rituxan, Abbott & Eisai's Humira, J&J's Remicade are likely to lose their patent protection in the coming years.
Asia Pacific is the fastest growing drug discovery services market owing to a huge patient pool and development in the pharmaceutical sector. The healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.
The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
Drug Discovery Services Market Segmentation:
The Global Drug Discovery Services Market is segmented by drug type, type of services, technology, therapeutic area, process, and end-user. On the basis of drug type, the drug discovery services market is classified as small molecule drug and biologics drug.
On the basis of types of services, the drug discovery services market is classified as Drug Metabolism and Pharmacokinetics (DMPK) services, pharmaceutical services, medicinal chemistry, and biological services.
On the basis of technology, the drug discovery services market is classified as high throughput screening, biochips, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics, and others. On the basis of therapeutic area, the drug discovery services market is classified as oncology, neurology, cardiovascular diseases, respiratory diseases, diabetes, and others.
On the basis of process, the drug discovery services market is classified as target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. On the basis of end-user, the drug discovery services market is segmented into hospitals and clinics, pharmaceutical companies, biotechnology companies, research institutes, and others.
Browse Complete Premium Research Report Enabled with Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870
MAJOR TABLE OF CONTENTS FOR GLOBAL DRUG DISCOVERY SERVICES MARKET RESEARCH REPORT - FORECAST TO 2023:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
Continue..
LIST OF Tables
Table 1 Drug Discovery Services Industry Synopsis, 2017–2023
Table 2 Drug Discovery Services Market Estimates And Forecast, 2017–2023, (USD Million)
Table 3 Drug Discovery Services Market, By Region, 2017–2023, (USD Million)
Table 4 Drug Discovery Services Market, By Drug Type, 2017–2023, (USD Million)
Table 5 Drug Discovery Services Market, By Types Of Services, 2017–2023, (USD Million)
Continue..
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Drug Discovery Services Market
Figure 3 Segmentation Market Dynamics For Drug Discovery Services Market
Figure 4 Global Drug Discovery Services Market Share, By Drug Type 2016
Figure 5 Global Drug Discovery Services Market Share, By Types Of Services 2016
Continue..
Ask to Experts @ https://www.marketresearchfuture.com/enquiry/5870
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Drug Discovery Services Market Classifications, Applications and Industry Chain by Drug Type-Small Molecule Drug, Biologics: Development by Type and Therapeutic Areas